Conquering Diseases

Study Of An Investigational Drug For Relapsed Or Refractory Multiple Myeloma


Seeking men and women whose multiple myeloma has returned following treatment or did not respond to treatment for a study of an investigational drug.


Participants in this study will be assigned to receive the investigational drug in combination with one of four different usual anti-myeloma treatments. Treatments are given in 28-day cycles and there are additional study visits on day 8, day 15 and day 22 of each cycle during the first 6 months of the study.

What we're hoping for

We are studying whether adding an investigational drug to anti-myeloma treatment is safe and effective for relapsed/refractory multiple myeloma.

Additional Information Identifier: NCT05259839

 Principal Investigator

Muthalagu  Ramanathan, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office



UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655